AATec Medical GmbH | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
AATec Medical GmbH

BRIEF

published on 09/18/2024 at 10:05, 2 months 3 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board

Scientific Advisory Board AATec Medical James Chalmers Bronchiectasis Recombinant AAT
PRESS RELEASE

published on 09/18/2024 at 10:00, 2 months 3 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board
AATec Medical welcomes Professor James Chalmers, a renowned expert in respiratory medicine, to its Scientific Advisory Board to advance product development in non-CF bronchiectasis

Scientific Advisory Board AATec Medical Professor James Chalmers Respiratory Medicine Non-CF Bronchiectasis
BRIEF

published on 07/24/2024 at 10:05, 3 months 28 days ago

AATec Medical Makes Significant Strides in First Year of Operations

Biotechnology Clinical Trials AATec Medical ATL-105 Inflammatory Lung Diseases
PRESS RELEASE

published on 07/24/2024 at 10:00, 3 months 28 days ago

AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT
AATec Medical reports significant progress in unlocking therapeutic potential of AAT for treating inflammatory lung diseases in its first year. Company advances lead candidate ATL-105 for NCFB

AATec Medical ATL-105 Inflammatory Lung Diseases Therapeutic Potential NCFB
BRIEF

published on 02/29/2024 at 09:30, 8 months 21 days ago

AATec Medical enriches its Scientific Council with the arrival of Professor Claus Franz Vogelmeier

AATec Medical Professor Claus Franz Vogelmeier Inflammatory Lung Diseases Scientific Council Alpha-1 Antitrypsin
PRESS RELEASE

published on 02/29/2024 at 09:30, 8 months 21 days ago

AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board
AATec Medical appoints Prof. Dr. Claus Franz Vogelmeier, a renowned pulmonology expert, to its Scientific Advisory Board, enhancing expertise in inflammatory lung diseases. Visit www.aatec-medical.com for details

Scientific Advisory Board AATec Medical Inflammatory Lung Diseases Alpha-1 Antitrypsin Professor Dr. Claus Franz Vogelmeier
PRESS RELEASE

published on 02/06/2024 at 09:00, 9 months 15 days ago

AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin
AATec Medical collaborates with German Federal Agency for Disruptive Innovation SPRIND to develop ATL-105, a recombinant alpha-1 antitrypsin platform for respiratory diseases, including viral infections and inflammatory diseases

Respiratory Diseases AATec Medical German Federal Agency For Disruptive Innovation SPRIND ATL-105 Recombinant Alpha-1 Antitrypsin
PRESS RELEASE

published on 10/31/2023 at 10:00, 1 year ago

AATec Medical and Beurer enter development collaboration for inhaled Alpha-1 Antitrypsin
PRESS RELEASE

published on 10/10/2023 at 11:00, 1 year 1 month ago

AATec Medical GmbH: AATec Medical Announces Creation of Scientific Advisory Board
PRESS RELEASE

published on 07/17/2023 at 11:00, 1 year 4 months ago

AATec Medical GmbH: AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin

Accesswire

Published on 11/21/2024 at 10:03, 30 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 33 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 33 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 58 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 8 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 28 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 31 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 33 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 33 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 32 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 13 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 48 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 48 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE